Higher Abatacept Exposure Decreases Acute GVHD Risk Without Increasing Adverse Events.

Takahashi T, Al-Kofahi M, Jaber M, Bratrude B, Betz KM, Suessmuth Y, Yu A, Neuberg DS, Choi SW, Davis JH, Duncan C, Giller RH, Grimley M, Harris AC, Jacobsohn DA, Lalefar NR, Farhadfar N, Pulsipher MA, Shenoy S, Petrovic A, Schultz KR, Yanik GA, Blazar BR, Horan JT, Watkins B, Langston A, Qayed M, Kean LS